Allergy Therapeutics (LON:AGY) Stock Price Crosses Above Fifty Day Moving Average - Time to Sell?

Key Points

• Allergy Therapeutics' stock price has recently crossed above its fifty day moving average of GBX 8.29, indicating potential upward momentum in the market.
• Despite this movement, the stock is down 3.6%, with a current price of GBX 8.30 and a market cap of £381.32 million.
• The company specializes in biotechnology for allergic disorders, selling proprietary and third-party products across multiple European countries.

Allergy Therapeutics plc (LON:AGY - )'s stock price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 8.29 ($0.11) and traded as high as GBX 8.50 ($0.11). Allergy Therapeutics shares last traded at GBX 8.30 ($0.11), with a volume of 572,018 shares trading hands.

Allergy Therapeutics Stock Down 3.6%

The company has a market cap of £381.32 million, a price-to-earnings ratio of -1,111.11, a PEG ratio of -30.70 and a beta of 1.40. The business has a fifty day moving average of GBX 8.29 and a two-hundred day moving average of GBX 7.53. The company has a current ratio of 1.63, a quick ratio of 1.48 and a debt-to-equity ratio of 835.48.

Allergy Therapeutics Company Profile

Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.